Free Trial
→ Why More Investors Are Using Family Trusts to Protect Their Wealth (From SmartAsset) (Ad)tc pixel Free DYN Stock Alerts

Dyne Therapeutics (DYN) SEC Filings & 10K Form

Dyne Therapeutics logo
$13.15 +0.16 (+1.23%)
Closing price 04:00 PM Eastern
Extended Trading
$13.15 0.00 (0.00%)
As of 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Dyne Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/09/2025
3:31 PM		Cox John (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025
3:14 PM		Cox John (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2025
3:45 PM		Dyne Therapeutics (Subject)
Kerr Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2025
9:34 AM		Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
08/04/2025
6:35 AM		Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
4:19 PM		Cox John (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2025
4:20 PM		Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2025
4:21 PM		Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2025
4:11 PM		Cox John (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
3:40 PM		Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2025
3:49 PM		Dyne Therapeutics (Filer)
Form 424B5
06/30/2025
3:43 PM		Dyne Therapeutics (Filer)
Form 424B5
06/17/2025
6:04 AM		Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
3:30 PM		Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
8:37 PM		Dyne Therapeutics (Issuer)
Stehman-Breen Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:38 PM		Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:38 PM		Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:39 PM		Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:40 PM		Dyne Therapeutics (Issuer)
Lubner David Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:41 PM		Dyne Therapeutics (Issuer)
HURWITZ EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
7:46 AM		Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
7:17 AM		Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
05/14/2025
11:16 AM		Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
05/08/2025
6:25 AM		Dyne Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:35 AM		Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
6:34 AM		Dyne Therapeutics (Filer)
Form DEF 14A
04/15/2025
6:35 AM		Dyne Therapeutics (Filer)
Form DEFA14A
04/15/2025
6:38 AM		Dyne Therapeutics (Filer)
Form ARS
04/01/2025
3:31 PM		Dyne Therapeutics (Issuer)
Lucera Erick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2025
6:31 AM		Dyne Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:08 PM		Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
3:07 PM		Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:08 PM		Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:09 PM		Cox John (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:10 PM		Dyne Therapeutics (Subject)
Kerr Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
6:25 AM		Dyne Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
6:35 AM		Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:20 AM		Dyne Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
11:22 AM		Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM		Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/12/2025
8:28 AM		Dyne Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/03/2025
4:07 PM		Dyne Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/29/2025
3:15 PM		Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:56 AM		Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
7:40 PM		Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:41 PM		Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:18 PM		Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:19 PM		Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:20 PM		Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:06 PM		Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
6:42 PM		Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:31 PM		Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:40 PM		Dyne Therapeutics (Subject)
Incerti Carlo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:46 PM		Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:32 PM		Atlas Venture Fund XI, L.P. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/14/2024
9:28 AM		Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/14/2024
8:27 AM		Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/14/2024
6:00 AM		Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
Form SC 13G/A
11/14/2024
5:34 AM		Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/12/2024
8:55 AM		Dyne Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
11/08/2024
4:31 PM		BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/04/2024
9:20 AM		Dyne Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
3:05 PM		Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
2:24 PM		BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
10/03/2024
3:05 PM		Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:05 PM		Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
3:05 PM		Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:51 PM		Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:52 PM		Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:52 PM		Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:20 PM		Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:21 PM		Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:23 PM		Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:24 PM		Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:05 PM		Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:DYN) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel